The Shanghai Global Ranking of Academic Subjects for 2025 was published yesterday and puts the University in the top 10 in Germany for 12—over half—of the subjects assessed. In five of these subjects, it has even made it into the top five.

Dr. Varun Venkataramani of the Faculty of Medicine at Heidelberg University and Dr. Niklas Klümper of the University Hospital Bonn have been awarded the Lisec Artz Prize for their outstanding cancer research. The University of Bonn Foundation and the University of Bonn Faculty of Medicine presented the awards to the two researchers on Tuesday, November 18, 2025 at the University Hospital Bonn (UKB) as part of the Cluster Science Days event held by the ImmunoSensation² Cluster of Excellence. The prize is worth a total of 15,000 euros.

Formally known as the European University of Brain and Technology, NeurotechEU is a consortium of top European universities formed to achieve advancements in teaching, research and innovation in the field of neurotechnology. Being a member of this alliance underscores the leading position the University of Bonn occupies internationally in one of the most dynamic research fields of our time. At the recent conference held in Spain, the Medical University of Innsbruck was officially inaugurated as the latest alliance member.

The German Research Foundation (DFG) is to provide €1.25 million in funding for a Reinhart Koselleck Project based at the University Hospital Bonn and the ImmunoSensation² Cluster of Excellence at the University of Bonn. The research team led by Professor Christoph Wilhelm, Professor for Immunopathology at the Institute of Clinical Chemistry and Clinical Pharmacology, plans to study how the body maintains its delicate balance with the intestinal flora during times of illness and hunger.

The University of Bonn is once again featured on the international “Highly Cited Researchers” list: According to Clarivate Analytics, the information service provider that compiles the list, a total of ten researchers are among the top one percent of the most influential in their field worldwide.

The Faculty of Medicine at the University of Bonn and the Research Institute for Medical Innovation at Radboud University Medical Center (Radboudumc) in Nijmegen, the Netherlands, plan to further deepen their international cooperation. To this end, Prof. Bernd Weber, Dean of the Medical Faculty in Bonn, traveled to the Netherlands for a two-day visit with a delegation of highly qualified researchers. The meeting followed the visit of Radboud University Rector Prof. José Sanders to Bonn earlier this year.

Researchers from the LIMES Institute at the University of Bonn, the German Center for Infection Research (DZIF), the German Center for Neurodegenerative Diseases (DZNE) and the University Hospital Cologne have decoded the immunological properties of what is known as extrapulmonary tuberculosis (EPTB) in the blood of patients suffering from the condition. Their findings, which have now been published in the journal “Nature Communications,” could help to develop new treatments and methods for diagnosing the illness.

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body’s immune system mistakenly attacks the protective myelin sheath of nerve fibers in the central nervous system. Although MOGAD induces symptoms similar to multiple sclerosis (MS), its underlying biology appears to be fundamentally different. Understanding these distinctions is crucial for developing effective, disease-specific treatments. A new international study under contribution of ImmunoSensation2 member Prof. Anne-Katrin Pröbstel and her team now sheds light on these immune differences. The results have been published in Science Translational Medicine.